IO Biotech was one of the finalists in the category Life Sciences at the EY Entrepreneur Of The Year national gala November 29 2018. IO Biotech is founded on groundbreaking research at the Center for Cancer Immune Therapy in Copenhagen identifying and characterizing intrinsic T-cells specific for immune suppressive proteins like IDO, TDO and Arginase.